SeaX Ventures bets US$1.65M on Skribe Medical’s AI heart patch for cancer patients

Surviving cancer can come with a cruel footnote. Some of the therapies that shrink tumours can quietly weaken the heart. Clinicians call it cancer therapy-related cardiac dysfunction (CTRCD), and catching it early usually means repeated echocardiograms, the heart ultrasounds that demand separate appointments, trained sonographers and, too often, a pause in treatment while oncologists wait […] The post SeaX Ventures bets US$1.65M on Skribe Medical’s AI heart patch for cancer patients appeared first on e27.